Development of Monocarboxylate Transporter 4 Inhibitor/Docetaxel-Loaded Multilayer Nanoparticles for Prostate Cancer Combination Therapy.

The proposed work seeks to develop and characterize a smart, multilayer MCT4i/DXT-loaded polylactide-glycolic acid nanoparticle for combination therapy in prostate cancer. The core of the smart LBL NPs is prepared by nanoprecipitation, and the sodium acetate "freeze-coating" technique is used to construct the multilayer nanoparticle. The size, zeta potential, entrapment efficiency, and nanoparticle surface chemistry are characterized by Malvern Panalytical Advanced Zeta Sizer. UV/VIS Spectrophotometer, transmission electron microscopy (TEM), and Fourier Transform Infrared spectrometer (FT-IR). The cytotoxicity of the different nanoformulations is assessed in the C4-2 cell line by MTS assay, and the mechanism of cell death is assessed by flow cytometry using an apoptosis assay. The TEM shows a multi-layer spherical nanoparticle. The multilayer nanoparticle is 255.539 nm in size, with an entrapment efficiency of 89.56 ± 1. 70% and 91.55 ± 7.82% for compound AZD0095 and docetaxel, respectively. The FTIR confirms that sodium acetate coats all the nanoformulation. Low-dose combination therapy effectively inhibits C4-2 cell growth. Smart nanoparticles exhibit dose-dependent cytotoxicity in C4-2 cells. Cell death occurs via apoptosis with docetaxel alone and via secondary necrosis with the combination therapy. The multilayer nanoparticle is a promising nanomedicine for combination therapy in prostate cancer.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Development and Technology
Published
2026-11-13
DOI
https://doi.org/10.1080/10837450.2026.2763654
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of Monocarboxylate Transporter 4 Inhibitor/Docetaxel-Loaded Multilayer Nanoparticles for Prostate Cancer Combination Therapy.

Karam F. A. Soliman, Ramesh Babu Badisa, Albert Nguessan Ngo, Wang Zhang et al.
2 links
Pharmaceutical Development and Technology
Nanoparticle-Based Drug Delivery
article

Development of Monocarboxylate Transporter 4 Inhibitor/Docetaxel-Loaded Multilayer Nanoparticles for Prostate Cancer Combination Therapy.

Karam F. A. Soliman, Ramesh Babu Badisa, Albert Nguessan Ngo, Wang Zhang, D. Sanjay Kumar, T’Onj D. McGriff, Lacy Myers, Kamryn Jackson
article en

Abstract

The proposed work seeks to develop and characterize a smart, multilayer MCT4i/DXT-loaded polylactide-glycolic acid nanoparticle for combination therapy in prostate cancer. The core of the smart LBL NPs is prepared by nanoprecipitation, and the sodium acetate "freeze-coating" technique is used to construct the multilayer nanoparticle. The size, zeta potential, entrapment efficiency, and nanoparticle surface chemistry are characterized by Malvern Panalytical Advanced Zeta Sizer. UV/VIS Spectrophotometer, transmission electron microscopy (TEM), and Fourier Transform Infrared spectrometer (FT-IR). The cytotoxicity of the different nanoformulations is assessed in the C4-2 cell line by MTS assay, and the mechanism of cell death is assessed by flow cytometry using an apoptosis assay. The TEM shows a multi-layer spherical nanoparticle. The multilayer nanoparticle is 255.539 nm in size, with an entrapment efficiency of 89.56 ± 1. 70% and 91.55 ± 7.82% for compound AZD0095 and docetaxel, respectively. The FTIR confirms that sodium acetate coats all the nanoformulation. Low-dose combination therapy effectively inhibits C4-2 cell growth. Smart nanoparticles exhibit dose-dependent cytotoxicity in C4-2 cells. Cell death occurs via apoptosis with docetaxel alone and via secondary necrosis with the combination therapy. The multilayer nanoparticle is a promising nanomedicine for combination therapy in prostate cancer.

Pharmaceutical Development and Technology
Florida Agricultural and Mechanical University (US)
National Institute on Minority Health and Health Disparities
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon